Johns Hopkins University School of Medicine
Licenses Acumenta Literature Lab™
Boston, MA – December 17, 2009: TThe Johns Hopkins Bayview Medical Center Lowe Family
Genomics Core has licensed Acumenta Corporation's Literature Lab™ to accelerate the understanding of biology associated with
experimentally derived gene lists.
A novel literature mining application, Literature Lab™ performs a statistical analysis on
the scientific literature as it relates to experimentally derived gene sets. It uniquely
solves two major challenges shared by virtually all investigators engaged in microarray
analysis and other genomic experimentation:
- Gaining a thorough understanding of the biological implications of their gene lists.
- Keeping up to date with scientific literature, and using it to accelerate their research.
“Literature Lab™ is an impressive tool for the functional annotation of gene lists using a
comprehensive gene name to text word association database which is regularly updated from
PubMed to be as current as possible. Our lab has used Literature Lab™ not only to confirm associations
generated using other functional enrichment analysis tools but also to extend these results even
further and by so doing, generate new insights into old data.” Chris Cheadle, Ph.D., Director
of the Core. “Literature Lab™ is not only fun to use but it should also prove to be a very useful
addition to any serious data-mining efforts.”
“Literature Lab™ provides a valuable biological perspective for researchers.” said Stephen C. Taylor,
Acumenta's CEO. “It analyzes over 10 million scientific journal abstracts to identify
statistically significant associations between Investigators' gene lists and 78,000 terms in
pathways and 17 other biological and biochemical domains.”
“Literature Lab™ automates and simplifies advanced literature mining.” said Paul Martinez, Acumenta's
Vice President of Sales and Marketing. “By rigorously identifying content that is related to a
scientist's current research, Literature Lab™ uncovers unanticipated and valuable new lines of insight. A
Literature Lab™ analysis on 200 genes performs the approximate equivalent of 15 Billion manual searches.”
Literature Lab™ analyses are provided by Acumenta as a service or as a turn-key
software application.
Acumenta Corporation, based in Boston, Massachusetts, is a software and information
company serving biotechnology and pharmaceutical firms and non-profit research
organizations. Acumenta builds applications that automate information gathering,
analysis and management tasks on public Web-based and proprietary external and
internal databases. Acumenta's software products and its curated Thesaurus of Gene
and Protein Nomenclature improve both the efficiency and quality of research in the life
sciences R&D function.
Contact: Paul Martinez
Title: Vice President Sales & Marketing
Phone: 617-379-0691
Email: pmartinez@Acumenta.com
URL: www.Acumenta.com |
